NURECA Share Price

₹ 300.00

+₹6.20 (2.11%)
1D
Last updated 02 Nov, 2026, 12:30 IST
NSE: NURECA
|
Medical Equipment

NURECA Share Price Today

As of 2 Nov 2026, NURECA share price is ₹300.00. The stock opened at ₹293.80, compared to its previous close of ₹293.80. During today's trading session, NURECA share price moved in the range of ₹288.00 to ₹303.90, with an average price of ₹295.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹204.00 and a high of ₹376.00. On the performance front, NURECA share price has increased by 10.24% over the last six months and is up 10.56% on a year-on-year basis.

Share price over the last 1 day rose from 291.00 to 300.00, ranging between 288.00 and 303.90.

₹288.00
2.11% up today
₹303.90
1D LOW
1D HIGH

NURECA Stock Insights

Latest Earning
Op Profit TrendUp by 24.60% QoQ
Latest Earning
Net Profit TrendUp by 31.92% QoQ
Latest Earning
Revenue TrendUp by 42.03% QoQ
Stock Performance
OutperformingBeat Nifty by 17.31 % in last 6 month
Shareholding Pattern
PromoterPromoter increased stake by 3.81%
Shareholding Pattern
FIIFII increased stake by 108.08%
NURECA stock performance
Open₹293.80
High₹303.90
Low₹288.00
Prev. close₹293.80
NURECA trading activity
Volume1,558
Average traded price₹298.63
Last traded time12:30:48 02 Nov
Last traded quantity3

Circuit
L
H
₹279.15
₹308.45
52-week
L
H
₹204.00
₹376.00
Mkt Cap Cr
285.11

P/E
59.88

P/B
1.52

ROA
2.06%
ROE
2.53%

ROCE
5.21%

Quick Ratio
4.88

EV/EBITDA
17.31

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Nureca has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Nureca appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Nureca revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Zomato3,31,007.03672.5510.571.09%1.58%4.15%2.3893.15
Paytm1,05,028.72123.126.333.49%5.15%5.84%2.5560.55
Nykaa1,00,464.57389.6769.875.62%13.87%16.71%0.56117.02
INFO EDGE (I) LTD77,162.0534.881.673.87%3.82%5.74%2.4727.61
Swiggy48,857.55-13.662.88-14.07%-21.08%-17.21%3.33-22.59
Policybazaar46,275.2861.846.338.6%10.36%10.98%4.4143.64
URBAN COMPANY LIMITED23,518.25-51.5211.84-17.22%-23.08%-17.31%4.34-75.15
PINE LABS LIMITED17,719.62111.22.941.14%2.66%4.67%1.5116.21
TBO TEK LIMITED16,688.8663.0410.762.84%15.76%14.37%1.0833.6
NAZARA TECHNOLOGIES LTD16,279.78926.633.570.24%0.35%0.51%2.0465.29

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

NURECA Company Background

ISIN
INE0DSF01015
Sector Market Cap
₹ 285.11 Cr

NOCIL Limited is one of largest rubber chemical manufacturers in India. It has state-of-the-art technology for manufacturing rubber chemicals. NOCIL Limited’s operations span over four decades. All products of the company are ISO-certified. NOCIL Limited operates as an entity of the diversified Arvind Mafatlal Group of Industries.

NOCIL Limited was incorporated in May 1961. The Mumbai-headquartered company commenced the production of rubber chemicals in the year 1975. NOCIL Limited is listed on both the National Stock Exchange and the BSE.

The company has expanded its operations to more than 40 countries across the world. NOCIL Limited offers over 20 products of rubber chemicals.

NOCIL Limited is a small-cap company with a market capitalisation of over ₹4,200 crore as of January 23, 2024. NOCIL Limited share price has surged more than 72% in the last three years.

NOCIL Limited business operations

The company set up its first state-of-the-art manufacturing unit in Navi Mumbai (Maharashtra) in 1976. The other manufacturing facility was set up by the company in Dahej (Gujarat) in 2013. NOCIL Limited has implemented a fully automated manufacturing facility, utilising advanced PLC/DCS controls. The company has spread its network all over India and in over 40 countries.

NOCIL Limited’s offerings include a diverse portfolio comprising more than 20 products. The company offers antidegradants or antioxidants. They ensure that a rubber product achieves its intended or optimal lifecycle. Pilflex Px 13 (6 PPD) and Pilnox TDQ (TMQ) are the top products in the antioxidant category of rubber chemicals. The majority of the overall consumption can be ascribed to these two products, accounting for more than 95% of the total usage. In this particular category, Pilnox SP represents another variant.

NOCIL Limited provides accelerators. It is a chemical added to rubber to make vulcanisation faster and more efficient, even at lower temperatures. It includes PVI(CTP), a pre-vulcanisation inhibitor, functioning as a vulcanisation retarder of the accelerator system. Included in this specific category are a range of supplementary products, namely Pilcure MBT, Pilcure MBTS, Pilcure CBS, Pilcure MOR, Pilcure TMT, Pilcure TBBS (NS), Pilcure DCBS, and Pilcure PVI.

NOCIL Limited manufactures a variety of products, extending beyond the automobile industry, to cater to specialised applications in diverse sectors. In this segment, the company offers products like Pilcure F, Pilcure ZDC, Pilcure ZBZDC, Pilcure ZMBT, Pilcure SDBC, Pilcure ZDBC, and Pilcure DHTS.

The products of the company have diverse applications, including areas like post-vulcanisation stabilisation and latex-based applications. NOCIL Limited aims to create unique products by incorporating innovative technologies and embracing Green Chemistry concepts.

NURECA Financial Highlights

  • Revenue: NURECA reported revenue of ₹155.06 crore in FY26 vs ₹122.10 crore in FY25. It showed an increase of 26.99% on a yearly basis.
  • Operating Profit: NURECA reported an operating profit of ₹4.98 crore in FY26 vs ₹1.34 crore in FY25. It showed an increase of 271.64% on a year-on-year basis.
  • Net Profit: NURECA reported a net profit of ₹2.08 crore in FY26 vs ₹0.85 crore in FY25. It showed an increase of 144.71% on a yearly basis.

NURECA Quarterly Result Highlights

  • NURECA reported revenue of ₹59.88 crore in Sep 2026, compared with ₹42.16 crore in Jun 2026, representing an increase of 42.03% on a quarter-on-quarter (QoQ) basis.
  • NURECA reported an operating profit of ₹5.52 crore in Sep 2026, compared with ₹4.43 crore in Jun 2026, representing an increase of 24.60% on a quarter-on-quarter (QoQ) basis.
  • NURECA reported a profit of ₹4.05 crore in Sep 2026, compared with ₹3.07 crore in Jun 2026, reflecting an increase of 31.92% on a QoQ basis.
  • The earnings per share (EPS) of NURECA stood at ₹2.11 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
70.68%
FII
0.22%
Other DII
0.24%
Retail and other
28.86%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jan 20260.08%
Mar 20260.28%
Jun 20260.11%
Sep 20260.22%

NURECA Investment Returns

1 day
-3.00%

1 week
-7.23%

1 month
-19.86%

1 year
+10.56%

3 years
-12.00%

5 years
-83.02%

NURECA Share Price History

NURECA share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹304.95 / ₹293.80
-3.00%
29 Oct 26
₹301.00 / ₹302.90
+0.80%
28 Oct 26
₹297.90 / ₹300.50
+0.87%
27 Oct 26
₹313.30 / ₹297.90
-3.97%
Show more

NURECA Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹146.96₹109.66₹91.93₹111.32
Other Income₹8.10₹12.44₹10.51₹7.11
Total Revenue₹155.06₹122.10₹102.44₹118.43
Total Expenses₹150.08₹120.75₹104.99₹129.17
Profit Before Tax₹4.98₹1.34-₹2.54-₹10.74
Tax₹2.90₹0.50-₹0.75-₹2.49
Profit After Tax₹2.08₹0.85-₹1.79-₹8.25
EPS - Basic₹2.11₹0.85-₹1.79-₹8.25
EPS - Diluted₹2.11₹0.85-₹1.79-₹8.25

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹4.98₹1.34-₹2.54-₹10.74
Income before WC changes₹10.40-₹7.24-₹9.30-₹14.22
Change in Assets-₹9.19-₹12.89₹4.99₹29.94
Change in Liabilities₹2.01₹2.42₹0.36-₹1.34
Change in WC-₹7.19-₹10.46₹5.34₹28.59
Cash flow from Operations₹3.30-₹19.08-₹2.71₹10.23
Cash flow from Investing₹14.49₹8.44₹17.58-₹16.46
Cash flow from Financing-₹19.56-₹0.17-₹1.30-₹1.51
Total Cash Flow-₹1.77-₹10.81₹13.56-₹7.74
Cash (Start of the year)₹3.24₹14.06₹0.50₹8.25
Cash (End of the year)₹1.46₹3.24₹14.06₹0.50

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹81.48₹20.02₹12.57₹20.02
Current Assets₹114.68₹189.95₹192.59₹186.56
Total Assets₹196.16₹209.98₹205.17₹206.58
Current Liabilities₹13.78₹12.40₹9.27₹8.88
Net Current Asset₹100.90₹177.55₹183.32₹177.68
Non-Current Liabilities₹1.62₹3.29₹2.78₹2.82
Equity Capital₹180.76₹194.29₹193.11₹194.88
Total Equity & Liabilities₹196.16₹209.98₹205.17₹206.58

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹147.21₹114.64₹94.52₹111.90
Other Income₹8.32₹12.54₹10.56₹7.17
Total Revenue₹155.53₹127.18₹105.09₹119.06
Total Expenses₹152.69₹127.64₹108.35₹130.02
Profit Before Tax₹2.84-₹0.46-₹3.27-₹10.96
Tax₹2.54₹0.21-₹0.83-₹2.54
Profit After Tax₹0.30-₹0.67-₹2.44-₹8.42
EPS - Basic₹0.30-₹0.67-₹2.44-₹8.42
EPS - Diluted₹0.30-₹0.67-₹2.44-₹8.42

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2.84-₹0.46-₹3.27-₹10.96
Income before WC changes₹7.76-₹8.60-₹10.24-₹14.59
Change in Assets-₹12.01-₹10.65₹5.65₹32.08
Change in Liabilities₹4.14₹1.46₹0.11-₹1.30
Change in WC-₹7.87-₹9.19₹5.76₹30.78
Cash flow from Operations₹0.32-₹18.82-₹3.00₹12.05
Cash flow from Investing₹16.50₹8.83₹17.84-₹18.30
Cash flow from Financing-₹18.61-₹0.79-₹1.28-₹1.51
Total Cash Flow-₹1.79-₹10.77₹13.56-₹7.76
Cash (Start of the year)₹3.19₹13.96₹0.40₹8.16
Cash (End of the year)₹1.40₹3.19₹13.96₹0.40

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹83.07₹21.78₹15.19₹22.68
Current Assets₹110.47₹184.38₹189.15₹184.00
Total Assets₹193.54₹206.16₹204.33₹206.68
Current Liabilities₹14.80₹10.44₹8.76₹8.62
Net Current Asset₹95.68₹173.94₹180.38₹175.39
Non-Current Liabilities₹1.59₹3.24₹2.71₹2.80
Equity Capital₹177.16₹192.48₹192.86₹195.26
Total Equity & Liabilities₹193.54₹206.16₹204.33₹206.68
* All values are in INR Crore
NURECA market depth
Bid quantityBid priceAsk priceAsk quantity
30295.130027
3629430134
1292.5302160
1292.23035
2291303.318
Total bid quantity70
Total ask quantity244
NURECA technical summary
Bearish indicators2
Neutral indicators3
Bullish indicators3
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
34.44
Neutral

ATR (14)
15.66
Neutral

STOCH(9,6)
3.38
Bullish

STOCH RSI (14)
0
Bullish

ADX(9)
36.15
Bearish

UO(9)
30.59
Neutral

ROC(12)
-9.15
Bearish

WillR(14)
-96.62
Bullish
Period
Simple value
Exponential vaue

5D
301.06
302.18

10D
311.84
309.47

20D
322.03
318.25

50D
327.61
321.22

100D
302.57
310.1
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

NURECA
Medical Equipment
Add Stock
Add Another

NURECA Returns Calculator

NURECA Share Price FAQs












Please be aware that NURECA stock prices are subject to continuous fluctuations due to various factors.